drugset / Trial / NCT05559554
A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Subjects
RandomizedParallel-groupQuadruple-blindOther
Summary
The purpose of this study is to evaluate the pharmacokinetic similarity of AK104 with different manufacturing process in healthy male subjects. Another purpose is to determine safety, and immunogenicity of AK104 with different manufacturing process.
Timeline
- Start
- 2022-10-25
- Primary completion
- 2023-03-24
- Completion
- 2023-04-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cadonilimab | Monoclonal antibody | — | Intravenous |
Indications
No indication recorded.